Amotz Shemi, PhD
Dr. Shemi is a co-founder of Silenseed and has served as the company’s Chief Executive Officer since its incorporation in 2008. Prior to founding Silenseed, from 2005 to 2008 Dr. Shemi served as the Senior Vice President Technologies at Medinol Ltd., a world leader in design, development and manufacturing of stent and stent delivery systems. Prior to that time Dr. Shemi was the chief executive of several private Israeli technology companies including Color-Chip Ltd. Dr. Shemi holds a Ph.D. degree in Physics from the Tel Aviv University. He is a single author and co-author of many scientific papers and a single inventor and co-inventor of about a dozen of patents.
Yaniv Zilber, CPA
Ettie Pirak, PhD
Director, Drug Development
Dr. Ettie Pirak, Ph.D. is a co-inventor and developer of the chimeric monoclonal antibody drug Cetuximab (Erbitux®); Dr Pirak serves as the Vice President of Technologies at Meytav Technological Incubator. Dr. Pirak founded Innovo Biotechnologies in 1998. She also serves as Senior Advisor at Vacciguard and Alon Therapeutics. She was also a Director of Research Collaboration at Compugen. Dr. Pirak serves as a Director of Quinova Rx Ltd., Angio B Ltd., Novotyr therapeutics and Protea. She serves as Member of Scientific Advisory Board at Allosterix Ltd. Dr. Pirak serves as a Director of Thera-P Ltd. Dr. Pirak was a Scientist at Weizmann Institute in the Chemical Immunology Department. She served as a Director of Collplant Holdings Ltd. Dr. Pirak worked for eight years as a Researcher at the Department of Chemical Immunology at the Weizmann Institute of Science. Dr. Pirak holds a Ph.D. from the Faculty of Chemistry, University of Louvain la Neuve, Belgium.
Yafit Stark, PhD
Global Clinical Development Strategy